Literature DB >> 26212314

Utility of an appropriate reporter assay: Heliotrine interferes with GAL4/upstream activation sequence-driven reporter gene systems.

Claudia Luckert1, Stefanie Hessel2, Alfonso Lampen3, Albert Braeuning3.   

Abstract

Reporter gene assays are widely used for the assessment of transcription factor activation following xenobiotic exposure of cells. A critical issue with such assays is the possibility of interference of test compounds with the test system, for example, by direct inhibition of the reporter enzyme. Here we show that the pyrrolizidine alkaloid heliotrine interferes with reporter signals derived from GAL4-based nuclear receptor transactivation assays by a mechanism independent of luciferase enzyme inhibition. These data highlight the necessity to conduct proper control experiments in order to avoid perturbation of reporter assays by test chemicals.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Firefly luciferase inhibition; Nuclear receptor; Transactivation assay

Mesh:

Substances:

Year:  2015        PMID: 26212314     DOI: 10.1016/j.ab.2015.07.009

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  2 in total

1.  Polycyclic Aromatic Hydrocarbons Activate the Aryl Hydrocarbon Receptor and the Constitutive Androstane Receptor to Regulate Xenobiotic Metabolism in Human Liver Cells.

Authors:  Lisa Goedtke; Heike Sprenger; Ute Hofmann; Felix F Schmidt; Helen S Hammer; Ulrich M Zanger; Oliver Poetz; Albrecht Seidel; Albert Braeuning; Stefanie Hessel-Pras
Journal:  Int J Mol Sci       Date:  2020-12-31       Impact factor: 5.923

2.  Metabolism of the Marine Phycotoxin PTX-2 and Its Effects on Hepatic Xenobiotic Metabolism: Activation of Nuclear Receptors and Modulation of the Phase I Cytochrome P450.

Authors:  Jimmy Alarcan; Estelle Dubreil; Antoine Huguet; Dominique Hurtaud-Pessel; Stefanie Hessel-Pras; Alfonso Lampen; Valérie Fessard; Ludovic Le Hegarat
Journal:  Toxins (Basel)       Date:  2017-07-05       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.